A multi-cancer early detection test showed a positive predictive accuracy of 75% and negative predictive accuracy of 98% in a population referred for diagnostic follow-up after presenting to primary care with symptoms of cancer. The SYMPLIFY study, abstract 1501, presented in an oral abstract session at the ASCO 2023 Annual Meeting, also found that the
World-first blood test for brain cancer may increase survival rates, say experts, Cancer
Cancer drugs for Africa… from Africa?
Importance of a Multi-Cancer Early Detection Test
Can Artificial Intelligence Help See Cancer in New Ways? - NCI
DermaSensors: The Future of Skin Cancer Detection
cdn.aarp.net/content/dam/aarp/health/conditions_tr
ACS CAN Policy Brief: Multi-Cancer Early Detection Tests
Multi-cancer blood test shows real promise in NHS study
Considerations in the Implementation of Multicancer Early Detection Tests – USC Schaeffer
